THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
Charles MacBain, CEO , NordhealthThe company provides business (practice) management software for human and animal health professionals. Nordhealth has developed Provet Cloud for the veterinary industry—an easy-to-use platform that helps veterinarian professionals save time and focus on what matters most— delivering quality care for patients and growing their business. Provet Cloud takes a unique approach with its open API, enabling anyone to connect to the private cloud. For instance, the company has an online booking system for scheduling appointments. But through their API, they also enable their customers to book through an event store—an online booking provider specialized for advertisers. This is just one tangible example of Provet Cloud’s guiding principle to provide the best possible experience for the client while also allowing clinics to partner with service providers of their liking.
While most clinics still use server-based software that leads to high-maintenance costs and continual server upgrades, Nordhealth’s cloud-based modular software empowers clinics to activate and deactivate features per their clients’ needs and reduce maintenance and administrative expenses. They also have an always-on and always up-to-date system wherever they may practice. Clinicians new to veterinary clinics can quickly adapt to the features, reducing the need for laborious training sessions and increasing in-practice efficiency.
“The value of Provet Cloud is in helping every clinic be more efficient, reduce administrative tasks, and improve relationships with their clients,” says Charles MacBain, CEO of Nordhealth. The company does this through a mix of deep integrations with third-party tools. The constant improvements to their UX are borne from practice feedback and usability tracking and giving practices tools needed to meet their client’s expectations regarding care and service. The goal for the practice is consistent and repeatable processes so they can focus on caring for their patients while also providing their clients with excellent communication and services.
In use at over 2,000 clinics and with more than 20,000 veterinary professionals globally, Provet Cloud has been built to help small independent practices and assist larger corporate chains facing complex issues across multiple clinics. One such challenge to solve for corporate or multi-clinic chains would be wanting to centralise pricing, controlling one of the main levers that enterprise medical centres use to standardize their qualityof- care experience. To solve this, Provet Cloud developed their master pricing tool where a central resource can view and update pricing across each of their clinics. Provet Cloud also accounts for multi-clinic reporting and business management needs, ensuring the solution is equally functional for large corporate groups as it is for smaller independent clinics.
When it comes to the pet owners’ user experience, Provet Cloud gives them access to their pet’s medical history, telemedicine options for connecting with their veterinarian, automated appointment reminders, and easy online scheduling. Furthermore, the product integrates with third-party providers such as wholesalers or insurance companies to bring additional services seamlessly to the pet parent. And because Provet Cloud reduces the time and manual effort prone to mistakes for data in-practice, pet parents also have the confidence that their pets’ health records are up-todate and accurate.
-
The value of Provet Cloud is in helping every clinic be more efficient, reduce administrative tasks, and improve relationships with their clients
In use at over 2,000 clinics and with more than 20,000 veterinary professionals globally, Provet Cloud has been built to help small independent practices and assist larger corporate chains facing complex issues across multiple clinics. One such challenge to solve for corporate or multi-clinic chains would be wanting to centralise pricing, controlling one of the main levers that enterprise medical centres use to standardize their qualityof- care experience. To solve this, Provet Cloud developed their master pricing tool where a central resource can view and update pricing across each of their clinics. Provet Cloud also accounts for multi-clinic reporting and business management needs, ensuring the solution is equally functional for large corporate groups as it is for smaller independent clinics.
As Nordhealth looks to the future, Provet Cloud continues to develop and innovate with key features such as fully integrated payments, enhanced business intelligence reporting, a complete digital whiteboard, treatment sheets solutions, and a refreshed standalone pet parent app—to help strengthen the quality of their customers’ relationships, service, and care.
For more information about Nordhealth and Provet Cloud, visit: https://www.provet.cloud/
Company
Nordhealth
Management
Charles MacBain, CEO , Nordhealth
Description
Nordhealth has developed Provet Cloud, an easy-to-use platform that helps veterinarian professionals save time and focus on what matters most—delivering quality care for patients and growing their business.
Nordhealth News
Insiders Of Nordhealth Reap Rewards After Their Investment Jumps Another €10m
While insider transactions are not the sole determinant in long-term investing decisions, it would be unwise to completely disregard them.
In the past year, the most substantial insider purchase was made by Chief Executive Officer Charles MacBain, who acquired kr13 million worth of shares at a price of kr20.00 per share. Although insider buying is generally viewed positively, it's worth noting that this purchase was well below the recent share price of kr27.00. While it suggests that insiders believe the stock was undervalued at lower prices, it doesn't provide much insight into their opinions on the current prices.
Insiders at Nordhealth have been buyers over the past year, with no reported insider sales. You can see the details of these insider transactions, including share prices, individuals involved, and transaction dates, in the chart below.
Nordhealth is not the only company witnessing insider buying. For those seeking investment opportunities, a list of growing companies with recent insider purchases can be found here.
When assessing a company, many investors like to gauge the level of insider ownership. Higher levels of insider ownership are typically viewed favorably, as they suggest that the company's leadership is aligned with the interests of shareholders. At present, Nordhealth insiders own 56% of the company, which is currently valued at approximately kr1.1 billion based on the recent share price. This significant insider ownership generally enhances the likelihood that the company is managed in the best interests of all shareholders.
In summary, while there haven't been any insider transactions in the last three months, the transactions over the past year are indicative of optimism among Nordhealth insiders. While these transactions provide some insight into the stock, it's important to consider the associated risks. We have identified two warning signs (one of which is concerning) that investors should be aware of before investing in Nordhealth.
Please note that the term "insiders" refers to individuals who report their transactions to the relevant regulatory body. The scope of our analysis covers open market transactions and private dispositions of direct interests but does not include derivative transactions or indirect interests.
If you have feedback on this article or concerns about its content, please feel free to reach out to us directly. Alternatively, you can email the editorial team at editorial-team@simplywallst.com.
This article by Simply Wall St is intended to provide general information and is based on historical data and analyst forecasts, using an unbiased methodology. It is not intended to serve as financial advice. It does not constitute a recommendation to buy or sell any stocks and does not take into account your specific objectives or financial situation. Our aim is to provide long-term-focused analysis driven by fundamental data. Please note that our analysis may not consider the latest price-sensitive company announcements or qualitative information. Simply Wall St does not have any positions in the mentioned stocks.